Regenxbio Current Ratio from 2010 to 2024

RGNX Stock  USD 9.18  0.45  4.67%   
Regenxbio Current Ratio yearly trend continues to be fairly stable with very little volatility. Current Ratio will likely drop to 2.44 in 2024. Current Ratio is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. View All Fundamentals
 
Current Ratio  
First Reported
2010-12-31
Previous Quarter
2.57132003
Current Value
2.44
Quarterly Volatility
7.50498397
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Regenxbio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Regenxbio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 18.2 M, Interest Expense of 6.5 M or Selling General Administrative of 47.8 M, as well as many indicators such as Price To Sales Ratio of 8.26, Dividend Yield of 0.0 or PTB Ratio of 2.64. Regenxbio financial statements analysis is a perfect complement when working with Regenxbio Valuation or Volatility modules.
  
Check out the analysis of Regenxbio Correlation against competitors.
For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

Latest Regenxbio's Current Ratio Growth Pattern

Below is the plot of the Current Ratio of Regenxbio over the last few years. It is a liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities. Regenxbio's Current Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Regenxbio's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 4.06 X10 Years Trend
Very volatile
   Current Ratio   
       Timeline  

Regenxbio Current Ratio Regression Statistics

Arithmetic Mean6.33
Geometric Mean2.76
Coefficient Of Variation118.58
Mean Deviation5.67
Median3.19
Standard Deviation7.50
Sample Variance56.32
Range26.8995
R-Value0.09
Mean Square Error60.12
R-Squared0.01
Significance0.74
Slope0.16
Total Sum of Squares788.55

Regenxbio Current Ratio History

2024 2.44
2023 2.57
2022 3.19
2021 3.98
2020 6.52
2019 10.25
2018 15.24

About Regenxbio Financial Statements

Regenxbio investors use historical fundamental indicators, such as Regenxbio's Current Ratio, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Regenxbio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Ratio 2.57  2.44 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.